Compare stocks

Novo Nordisk A/S is a global healthcare company specializing in diabetes care and hormone replacement therapies. Headquartered in Bagsværd, Denmark, the company is renowned for its insulin and GLP-1 receptor agonists for treating diabetes, as well as products for obesity care and growth hormone therapy. Established in 1923, Novo Nordisk has grown its presence worldwide, operating in numerous countries with a substantial workforce. The company leverages its scientific research capabilities to maintain a strong position in the biopharmaceutical industry, focusing heavily on innovation in chronic disease management. Its integrated supply and production facilities support its strategic emphasis on quality control and sustainable production practices.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.